NorthWest Biotherapeutics Inc (NWBO)

[alexander77]

Feb 2017 “NW Bio Announces Lifting of Clinical Hold on DCVax®-L Phase III Trial By FDA; Progression-Free Survival Events Reached; Overall Survival Events Not Yet Reached

https://nwbio.com/nw-bio-announces-lifting-clinical-hold-dcvax-l-phase-iii-trial-fda-progression-free-survival-events-reached-overall-survival-events-not-yet-reached/

AND THE NUMBER OF overal survival events is still not reached!! $$$$$

Key word here as well “pseudo-progression”

Also don’t forget from earlier trials:
“As previously stated, the Company’s steady progress continues to reflect the growing interest from both physicians and patients, and a growing awareness of the positive data from the Company’s prior clinical trials for GBM brain cancer. In those trials, patients who received DCVax® showed a median survival of 3 years compared with median survival of 14.6 months for patients who received standard of care (surgery, radiation and chemotherapy). Patients who received DCVax®also experienced a substantially longer time to tumor recurrence: a median of 2 years, compared with 6.9 months in patients who received standard of care. DCVax® was well-tolerated, with no toxic side effects.”
https://nwbio.com/nw-bio-reaches-25-clinical-trial-sites-open-and-recruiting-by-the-end-of-q4-2011-2/